EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 28 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $18,761,000 | -49.1% | 449,479 | -43.2% | 0.57% | -25.6% |
Q4 2020 | $36,865,000 | +36.3% | 791,600 | +24.4% | 0.76% | -27.1% |
Q3 2020 | $27,040,000 | -49.7% | 636,538 | -43.2% | 1.05% | -60.7% |
Q2 2020 | $53,749,000 | -5.4% | 1,120,235 | -9.3% | 2.66% | -30.9% |
Q1 2020 | $56,803,000 | -19.3% | 1,234,856 | +5.4% | 3.86% | +30.1% |
Q4 2019 | $70,406,000 | +13.8% | 1,171,880 | +7.2% | 2.96% | -1.6% |
Q3 2019 | $61,848,000 | -14.6% | 1,093,299 | -15.9% | 3.01% | +0.2% |
Q2 2019 | $72,384,000 | +37.2% | 1,300,000 | +24.4% | 3.01% | +29.9% |
Q1 2019 | $52,777,000 | +24.8% | 1,045,311 | -0.4% | 2.32% | +10.8% |
Q4 2018 | $42,304,000 | -17.7% | 1,050,000 | +41.6% | 2.09% | +11.6% |
Q3 2018 | $51,403,000 | -38.4% | 741,426 | -32.8% | 1.87% | -39.8% |
Q2 2018 | $83,495,000 | +50.7% | 1,103,556 | +5.0% | 3.11% | +26.1% |
Q1 2018 | $55,392,000 | +0.1% | 1,051,274 | +1.4% | 2.47% | -2.2% |
Q4 2017 | $55,358,000 | +2.2% | 1,036,274 | +14.1% | 2.52% | -21.9% |
Q3 2017 | $54,166,000 | +68.8% | 908,220 | +123.3% | 3.23% | +81.7% |
Q2 2017 | $32,082,000 | -20.8% | 406,663 | -16.7% | 1.78% | -24.7% |
Q1 2017 | $40,485,000 | -12.0% | 488,128 | -15.8% | 2.36% | -33.7% |
Q4 2016 | $45,998,000 | +4.3% | 579,753 | -7.9% | 3.56% | -11.3% |
Q3 2016 | $44,083,000 | +80.5% | 629,753 | 0.0% | 4.01% | +62.4% |
Q2 2016 | $24,428,000 | -59.0% | 629,753 | -57.2% | 2.47% | -56.0% |
Q1 2016 | $59,624,000 | -2.5% | 1,472,197 | +113.4% | 5.61% | -15.0% |
Q4 2015 | $61,182,000 | +65.1% | 690,000 | +37.8% | 6.60% | +95.5% |
Q3 2015 | $37,059,000 | -9.0% | 500,591 | -0.6% | 3.38% | -10.7% |
Q2 2015 | $40,720,000 | +55.6% | 503,585 | -19.4% | 3.78% | -0.8% |
Q1 2015 | $26,178,000 | +111.1% | 624,920 | -21.9% | 3.82% | +94.1% |
Q4 2014 | $12,400,000 | +46.9% | 800,000 | +19.9% | 1.97% | +57.5% |
Q3 2014 | $8,443,000 | +38.0% | 667,462 | +56.4% | 1.25% | +56.4% |
Q2 2014 | $6,117,000 | +129.4% | 426,900 | +104.1% | 0.80% | +163.4% |
Q1 2014 | $2,667,000 | – | 209,200 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 121,014 | $5,377,000 | 1.78% |
Smith, Graham & Co., Investment Advisors, LP | 232,343 | $10,323,000 | 1.28% |
GLOBEFLEX CAPITAL L P | 73,205 | $3,252,000 | 0.79% |
SummerHaven Investment Management, LLC | 18,604 | $827,000 | 0.56% |
BRANDES INVESTMENT PARTNERS, LP | 464,292 | $20,628,000 | 0.50% |
Capital Impact Advisors, LLC | 11,728 | $521,000 | 0.48% |
Watershed Asset Management, L.L.C. | 5,756 | $256,000 | 0.32% |
Foundry Partners, LLC | 84,325 | $3,747,000 | 0.23% |
Summit Global Investments | 33,738 | $1,499,000 | 0.13% |
SCOUT INVESTMENTS, INC. | 147,034 | $6,533,000 | 0.13% |